4.7 Article

Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine

Chong Guo et al.

Summary: Ovarian cancer is a highly lethal gynecological cancer, and its treatment options include platinum-based chemotherapy and cytoreductive surgery. However, platinum resistance is a major challenge, with up to 80% of patients becoming refractory to therapy. Understanding the underlying molecular mechanisms of drug resistance is crucial for therapeutic management and the development of novel drug targets.

GENES & DISEASES (2022)

Article Oncology

Multi-drug-resistance efflux in cisplatin-naive and cisplatin-exposed A2780 ovarian cancer cells responds differently to cell culture dimensionality

Vasilij Koshkin et al.

Summary: Chemotherapy failure is often due to chemoresistance, with Multi-drug resistance (MDR) being a major contributing factor. Understanding how cell clustering affects intrinsic and acquired MDR can provide insights for developing new therapeutic strategies. Assessing cultured monolayers and spheroids of ovarian cancer cells revealed differences in MDR activity, with potential implications for targeting circulating tumor cell clusters.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

Review Pharmacology & Pharmacy

Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer

Chao Dong et al.

Summary: Hyperactivation of the PI3K/AKT/mTOR pathway is associated with drug resistance and cancer progression in breast cancer patients. Current research is focusing on developing drugs targeting this pathway to overcome acquired resistance to standard therapies.

FRONTIERS IN PHARMACOLOGY (2021)

Review Cell Biology

The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies

Vivek Kumar et al.

Summary: Resistance to therapy is a major challenge in cancer management, with cancer cells rewiring their cellular processes to resist the deleterious effects of various therapeutic approaches. Understanding the role of developmental pathways in cancer and their contribution to resistance can lead to insights for developing novel therapeutic approaches. Recognizing the importance of molecular networks in overcoming drug resistance can provide a rational basis for improving cancer treatment with safer and more effective combined therapeutic strategies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Oncology

The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review

Federica Rascio et al.

Summary: The PI3K/Akt pathway plays a crucial role in drug resistance in cancer by impacting tumor cell growth and metastasis through different signaling pathways. Its multi-level deregulation contributes to resistance in various cancer types. Understanding the pathway is essential in developing potential inhibition strategies for overcoming drug resistance.

CANCERS (2021)

Review Cell Biology

Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming

Xiaowei Lai et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Oncology

Risk factors for early death among ovarian cancer patients: a nationwide cohort study

Berit Jul Mosgaard et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients

Eileen Deuster et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism

Shan-Shan Li et al.

JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)

Review Biochemistry & Molecular Biology

The Aryl Hydrocarbon Receptor and the Nervous System

Ludmila Juricek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Multidisciplinary Sciences

Familial Ovarian Cancer Clusters with Other Cancers

Guoqiao Zheng et al.

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway

M. Silginer et al.

ONCOGENE (2016)

Article Biochemistry & Molecular Biology

The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells

Kanae Bekki et al.

PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY (2015)

Review Biochemistry & Molecular Biology

Ovarian cancer stem cells: Molecular concepts and relevance as therapeutic targets

Nuzhat Ahmed et al.

MOLECULAR ASPECTS OF MEDICINE (2014)

Article Cell Biology

Inhibition of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin depends on protein biosynthesis

Martin Chopra et al.

CELL BIOLOGY AND TOXICOLOGY (2010)

Review Environmental Sciences

Risk factors for ovarian cancer: An overview with emphasis on hormonal factors

Fariba Salehi et al.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2008)